<DOC>
	<DOCNO>NCT00751426</DOCNO>
	<brief_summary>Psychiatric disorder drug addiction often regard contraindication use Interferon-alpha patient chronic hepatitis C. The investigator aim is/was get prospective data adherence , efficacy mental side effect IFN-alpha treatment different psychiatric risk group compare control . In prospective trial , 81 patient chronic hepatitis C ( positive HCV-RNA elevate ALT ) psychiatric disorder ( n=16 ) , methadone substitution ( n=21 ) , former drug addiction ( n=21 ) control without psychiatric history addiction ( n=23 ) be/were treat combination IFN-alpha-2a 3 x 3 Mio U/week ribavirin ( 1000-1200 mg/day ) .</brief_summary>
	<brief_title>Treatment Hepatitis C Psychiatric Patients</brief_title>
	<detailed_description>Patients Munich University outpatient department psychiatry gastroenterology well inpatient elevate transaminase test HCV-infection consider trial avoid positive negative selection . Medical inclusion criterion detectable serum HCV-RNA level PCR-based assay ( AMPLICOR® , Roche Diagnostics , Branchburg , NJ ) 6 month elevate alanine aminotransferase ( ALT &gt; 30 U/L , normal &lt; 24 U/L ) . General exclusion criterion presence liver disease , Child B C cirrhosis , severe cardiac neurological disease , co-infection hepatitis B HIV , hepatocellular carcinoma evaluate ultrasound alpha-fetoprotein , autoimmune disorder , neutrophil count 1500 per cubic millimetre , platelet count 75000 per cubic millimetre .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Medical inclusion criterion detectable serum HCVRNA level PCRbased assay ( AMPLICOR® , Roche Diagnostics , Branchburg , NJ ) 6 month elevate alanine aminotransferase ( ALT &gt; 30 U/L , normal &lt; 24 U/L ) . General exclusion criterion presence liver disease Child B C cirrhosis Severe cardiac neurological disease Coinfection hepatitis B HIV Hepatocellular carcinoma evaluate ultrasound alphafetoprotein Autoimmune disorder Neutrophil count 1500 per cubic millimetre Platelet count 75000 per cubic millimetre</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Interferon-alpha</keyword>
	<keyword>hepatitis c</keyword>
	<keyword>Drug addiction</keyword>
	<keyword>methadone</keyword>
	<keyword>psychiatric disorder</keyword>
	<keyword>Safety efficacy Interferon-alpha patient psychiatric disorder .</keyword>
</DOC>